Growth Metrics

Innoviva (INVA) Research & Development (2016 - 2026)

Innoviva filings provide 14 years of Research & Development readings, the most recent being $9.4 million for Q3 2025.

  • On a quarterly basis, Research & Development rose 164.71% to $9.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $25.3 million, a 81.21% increase, with the full-year FY2025 number at $30.6 million, up 124.14% from a year prior.
  • Research & Development hit $9.4 million in Q3 2025 for Innoviva, up from $8.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $15.0 million in Q2 2023 to a low of $38000.0 in Q2 2021.
  • Median Research & Development over the past 5 years was $4.4 million (2025), compared with a mean of $6.4 million.
  • Biggest five-year swings in Research & Development: tumbled 93.2% in 2021 and later skyrocketed 36436.84% in 2022.
  • Innoviva's Research & Development stood at $449000.0 in 2021, then skyrocketed by 2511.36% to $11.7 million in 2022, then tumbled by 65.98% to $4.0 million in 2023, then fell by 10.98% to $3.6 million in 2024, then soared by 164.71% to $9.4 million in 2025.
  • The last three reported values for Research & Development were $9.4 million (Q3 2025), $8.0 million (Q2 2025), and $4.4 million (Q1 2025) per Business Quant data.